On December 31, 2018 Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, reported that Bob Azelby, Alder’s president and chief executive officer, will provide a business overview and update at the 37th Annual J.P. Morgan Healthcare Conference at 8:00 am PT on Tuesday, January 8, 2019 in San Francisco, CA (Press release, Alder Biopharmaceuticals, DEC 31, 2018, View Source [SID1234532314]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Both the presentation and question and answer session that follows at 8:30 am PT will be webcast live on the Events & Presentations page of the Investors section of Alder’s website at View Source, or by following the links below in your web browser. An archived replay of each webcast will be available on Alder’s website for at least 30 days after each live event concludes.

Presentation Link:View Source
Q&A Link:View Source